2. Academic Validation
  3. Eckol from Ecklonia cava Suppresses Immunoglobulin E-mediated Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mice

Eckol from Ecklonia cava Suppresses Immunoglobulin E-mediated Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mice

  • Nutrients. 2020 May 9;12(5):1361. doi: 10.3390/nu12051361.
Eui Jeong Han 1,  Hyun-Soo Kim 2,  K K A Sanjeewa 3,  K H I N M Herath 4,  You-Jin Jeon 3,  Youngheun Jee 4,  Jeongjun Lee 5,  Taehee Kim 5,  Sun-Yup Shim 6,  Ginnae Ahn 1 7
Affiliations

Affiliations

  • 1 Department of Food Technology and Nutrition, Chonnam National University, Yeosu 59626, Korea.
  • 2 National Marine Biodiversity Institute of Korea, 75, Jangsan-ro 101 gil, Janghang-eup, Seocheon 33662, Korea.
  • 3 Department of Marine Life Science, Jeju National University, Jeju 63243, Korea.
  • 4 Department of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju 63243, Korea.
  • 5 Naturetech, 29-8, Yongjeong-gil, Chopyeong-myeon, Jincheon-gun, Chungbuk 27858, Korea.
  • 6 Fisheries Science Institute, Chonnam National University, Daehak-Ro, Yeosu 59626, Korea.
  • 7 Department of Marine Bio-Food Sciences, Chonnam National University, Yeosu 59626, Korea.
PMID: 32397556 DOI: 10.3390/nu12051361
Abstract

Eckol, a precursor compound belonging to the dibenzo-1,4-dioxin class of phlorotannins, is a phloroglucinol derivative that exerts various activities. In the present study, we investigated the antiallergic effects of eckol isolated from the marine brown algae, Ecklonia cava using immunoglobulin E (IgE)/bovine serum albumin (BSA)-stimulated mouse bone marrow-derived cultured mast cells (BMCMC) and a mouse model of anaphylaxis. Eckol inhibited IgE/BSA-induced BMCMC degranulation by reducing β-hexosaminidase release. A flow cytometric analysis revealed that eckol decreases FcεRI expression on cell surface and IgE binding to the FcεRI in BMCMC. Moreover, eckol suppressed the production of the cytokines, interleukin (IL)-4, IL-5, IL-6, and IL-13 and the chemokine, thymus activation-regulated chemokine (TARC) by downregulating, IκB-α degradation and NF-κB nuclear translocation. Furthermore, it attenuated the passive cutaneous anaphylactic reaction induced by IgE/BSA-stimulation in the ear of BALB/c mice. These results suggest that eckol is a potential therapeutic candidate for the prevention and treatment of allergic disorders.

Keywords

Ecklonia cava; Eckol; bone marrow-derived cultured mast cells; immunoglobulin E; passive cutaneous anaphylaxis.

Figures
Products